This security is delisted
The previous Warner Chilcott Plc dividend was 25c and it went ex almost 12 years ago and it was paid almost 12 years ago.
There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 7.0.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | – |
| Type | Final | – |
| Per share | 25c | – |
| Declaration date | 07 May 2013 (Tue) | – |
| Ex-div date | 29 May 2013 (Wed) | – |
| Pay date | 14 Jun 2013 (Fri) | – |
Enter the number of Warner Chilcott Plc shares you hold and we'll calculate your dividend payments:
Sign up for Warner Chilcott Plc and we'll email you the dividend information when they declare.
Add Warner Chilcott Plc to receive free notifications when they declare their dividends.
Your account is set up to receive Warner Chilcott Plc notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Paid | Final | 07 May 2013 | 29 May 2013 | 14 Jun 2013 | USD | — | 25c | |
| Paid | Interim | 06 Nov 2012 | 30 Nov 2012 | 14 Dec 2012 | USD | — | 25c | |
| Paid | Special | – | 31 Aug 2012 | 10 Sep 2012 | USD | — | 400c | |
| Paid | Special | – | 30 Aug 2010 | 08 Sep 2010 | USD | — | 850c | |
| Paid | Final | – | 31 Dec 2009 | 31 Dec 2009 | USD | — | 0c | |
| Paid | Final | – | 31 Dec 2008 | 31 Dec 2008 | USD | — | 0c | |
| Paid | Final | – | 31 Dec 2007 | 31 Dec 2007 | USD | — | 0c | |
| Paid | Final | – | 31 Dec 2006 | 31 Dec 2006 | USD | — | 0c |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 0.0c | 0% |
| 2013 | 50.0c | 100% |
October 1, 2013: Actavis (NYSE: ACT) announced the acquisition of Warner Chilcott plc
Warner Chilcott is a global specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the U.S. and Western European pharmaceuticals markets. Since being spun out of Warner-Lambert in 1996, Warner Chilcott has evolved, through a series of acquisitions and divestitures, from a small seller of undifferentiated products to a fully integrated pharmaceutical company with a broad portfolio of leading branded products. The acquisition of The Procter & Gamble Company's global branded pharmaceuticals business on October 30, 2009 transformed Warner Chilcott into a global pharmaceuticals company with significant scale and geographic reach. Today, Warner Chilcott has an expanded sales force and infrastructure to better promote products in the U.S., major Western European and other markets, increased diversity of revenue sources, enhanced product development capabilities and a deeper product development pipeline.
Headquartered in Dublin, Ireland, Warner Chilcott has employees in 12 countries in North America and Western Europe. The Company's manufacturing facilities are located in Puerto Rico, Northern Ireland and Germany. Warner Chilcott is listed on the Nasdaq Stock Exchange and trades under the symbol WCRX.
Warner Chilcott paid their First Semi-Annual Cash Dividend December 14, 2012
